Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.
Latest website image capture
Clouds background image

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page

  1. Check
    7 days ago
    Change Detected
    Summary
    New revision entry v3.5.0 added to the study record history. Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-25T20:55:58.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision v3.4.3 was added to the Version History. Revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T14:36:19.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed a government funding lapse notice and Revision: v3.4.1.
    Difference
    0.8%
    Check dated 2026-02-11T02:07:29.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH operating status, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-03T23:53:22.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Show glossary toggle added; UI legends explain color-coded additions (green) and deletions (red), and the revision label updated to v3.4.0. No core content changes occurred; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-27T21:41:24.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    Added a new revision entry 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the page history; these are administrative updates and do not affect the study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T09:09:51.000Z thumbnail image

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC

Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.